Omnicell(US:OMCL) Businesswire·2025-10-30 10:30Core Insights - Omnicell reported its financial results for the third quarter of 2025, highlighting significant growth in revenue and net income compared to the previous year [1] Financial Performance - The company achieved a revenue of $250 million in Q3 2025, representing a 15% increase from $217 million in Q3 2024 [1] - Net income for the quarter was reported at $30 million, up from $25 million in the same quarter last year, indicating a 20% year-over-year growth [1] - Earnings per share (EPS) increased to $0.75, compared to $0.62 in Q3 2024, reflecting a 21% rise [1] Operational Highlights - Omnicell's gross margin improved to 55% in Q3 2025, up from 52% in Q3 2024, showcasing enhanced operational efficiency [1] - The company expanded its customer base by 10%, adding several new healthcare facilities to its portfolio [1] - Investments in technology and automation contributed to a 25% increase in productivity within its operations [1]